A Study of SYNT001 in Healthy Volunteers

NCT03643627 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: SYNT001
DRUG: Placebo

Sponsor

Syntimmune, Inc.